Skip to content

Electrophysiological Comparison of mAP and mADM Using EMG

Electrophysiological Comparison of mAP and mADM Using EMG

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03360825
Enrollment
56
Registered
2017-12-04
Start date
2017-11-20
Completion date
2018-03-20
Last updated
2019-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Brief summary

The primary aim of this clinical investigation is to examine a prototype of a quantitative monitoring instrument that will meet most, if not all, of the clinical requirements.

Detailed description

This is a blinded, single-center, prospective study in patients during surgery, requiring use of neuromuscular blockade. Neurostimulation will be used to monitor objective responses, as per current clinical routine. Data collection of Tetragraph EMG responses will be unavailable to the clinician for clinical decision-making, as per current clinical routine, but will be stored on the interfaced SD card.

Interventions

The TetraGraph is a dedicated neuromuscular stimulator / recorder intended to evoke, record, and analyze muscle action potentials during surgical procedures

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age 18 years or older. 2. American Society of Anesthesiology (ASA) physical status I-III criteria (Table I). 3. Subject has provided verbal consent 4. BMI \<39

Exclusion criteria

1. Presence of an underlying neuromuscular disease. 2. Presence of renal or hepatic disease. 3. Subject has open skin sores in the locations needed for electrode application (forearms). 4. Patients on oral anticholinesterase, anti-seizure medications, and magnesium sulfate.

Design outcomes

Primary

MeasureTime frameDescription
Primary performance assessment of TetraGraph deviceDuration of surgeryAgreement between the mAP and mADM EMG based TOF ratios

Secondary

MeasureTime frameDescription
Secondary performance assessment of TetraGraph deviceDuration of surgeryCorrelation between stimulation current and T1 twitch height in the two muscles

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026